Ambalal Sarabhai Enterprises touches roof as its arm’s JV gets test license to manufacture COVID-19 diagnostic kits

19 Mar 2020 Evaluate

Ambalal Sarabhai Enterprises is locked at upper circuit limit of Rs. 13.20, up by 0.60 points or 4.76% from its previous closing of Rs. 12.60 on the BSE.

The scrip opened at Rs. 13.15 and has touched a high and low of Rs. 13.20 and Rs. 13.15 respectively. So far 15508 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 21.60 on 10-Jan-2020 and a 52 week low of Rs. 9.04 on 26-Oct-2018.

Last one week high and low of the scrip stood at Rs. 14.20 and Rs. 12.50 respectively. The current market cap of the company is Rs. 101.16 crore.

The promoters holding in the company stood at 30.76% while Institutions and Non-Institutions held 0.01% and 69.23% respectively.

CoSara Diagnostics (CoSara), a Joint Venture (JV) company of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises and CoDiagnostics Inc, USA, a Gujarat, India based molecular diagnostic Company, has received the Test License from Central Drugs Standard Control Organisation (CDSCO) to manufacture corona virus (COVID-19) diagnostic test kits.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

53.77 7.36 (15.86%)
03-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1531.05
Dr. Reddys Lab 6428.05
Cipla 1482.30
Zydus Lifesciences 1093.45
Lupin 1637.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.